# VARIZIG

NDC: 49591-126
Generic name: HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN
Labeler / Manufacturer: Kamada Ltd.
Product type: PLASMA DERIVATIVE
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR
Marketing started: 20240301

FDA application: BLA125430

## Active ingredients

- HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN: 125 [iU]/1.2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"49591-126"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=49591-126